This paper reviews recent applications of mechanical ventilation such as controlled hypo ventilation in acute asthma, domiciliary nocturnal ventilation in chronic respiratory failure due to neuromuscular disease and improvement of left ventricular performance by raised intrathoracic pressure. Established uses of mechanical ventilation include control of respiratory failure, intracranial pressure and pulmonary hypertension while other uses such as internal splinting of flail chest, simultaneous ventilation-compression cardiopulmonary resuscitation and prophylactic postoperative ventilation are more controversial.
ventilation (IPPV)/IMV with or without PEEP is well established in acute respiratory failure due to conditions such as pneumonia,6,7 acute cardiogenic pulmonary oedema 8 ,9 and adult respiratory distress syndrome (ARDS). 10
Obstructive lung disease
In acute exacerbations of chronic obstructive pulmonary disease, assisted ventilation can be lifesaving in younger patients and those with a reversible precipitating cause of their acute deterioration. It is not indicated for the terminal phase of progressive respiratory failure. 11 In the past, the aim of IPPV in acute asthma was to achieve normal blood gases. This may require airway pressures of 70-100 mmHg (9.3-13.3 kPa)12 with a high risk of barotrauma and reduced cardiac output: both factors contribute to the higher mortality among patients needing IPPV for acute asthma. [13] [14] [15] Recently, controlled hypoventilation has been advocated in status asthmaticus, based on the use of an airway pressure (Paw) 50 cm H20 (5.0 kPa) or less while accepting a high Paco2. 16, 17 The aim of mechanical ventilation used in this way is to prevent increasing 3. To increase CO 2 excretion: a. To reduce Pac02 in order i. to achieve normal ECF [H + 1 in metabolic acidosis ii. to cause cerebral vasoconstriction iii. to restore cerebrovascular autoregulation iv. to reduce pulmonary vascular resistance b. in abnormal states in which CO 2 production is increased 4. To reduce work of breathing in cardiorespiratory failure. 5. Raised intrathoracic pressure reduces afterload on the failing left ventricle. 6 . Prophylactic mechanical ventilation with or without PEEP.
7. Mask IPPB in asthma, chronic obstructive pulmonary disease and postoperatively. 8 . To increase cardiac output in simultaneous ventilation -compression cardiopulmonary resuscitation. 9 . Internal splinting of flail chest by mechanical ventilation.
acidaemia while allowing time for bronchodilator drugs and steroids to act, and for therapeutic bronchoscopy if necessary. Some studies have found increased mortality associated with hypercarbia in acute asthma 13 · 18 but in James' series only one of 43 patients with PaC02 greater than 60 mmHg (8 kPa) died. 19 Extracellular fluid (ECF) hydrogen ion concentration can be controlled temporarily with bicarbonate infusion in acute respiratory acidosis,17,20,21 although not all centres would agree with bicarbonate administration in asthma. 14, 22, 23 If intracellular (ICF) rather than ECF hydrogen ion affects the smooth muscle relaxation response to {32 sympathomimetics as is the case with heart muscle, then allowing PaC02 to rise may adversely affect the response. This is because cell membranes are freely permeable to C02 but not to HC03 and H +. Also, administration of NaHC0 3 which increases PaC02 will increase ICF PC02 and thus increase ICF hydrogen ion concentration. 24 The only data available show that respiratory and metabolic acidosis are equally effective in reducing the bronchodilator response to {32 agonists. 25 Controlled hypoventilation with or without bicarbonate infusion is now widely advocated 16.26·28 but remains controversial.
The use of PEEP ICP AP in asthma is discussed elsewhere in this symposium issue. 31, [34] [35] [36] [37] Central Nervous System (CNS) disorders 1. In acute CNS disorders causing acute respiratory failure (e.g. head trauma, drug intoxication, electrolyte imbalance and CNS infections), mechanical ventilation is indicated to maintain life until the underlying cause is resolved. 2. In acute exacerbations of chronic CNS disorders causing acute respiratory failure (e.g. Ondine's curse, Leigh disease and some cases of intractable epilepsy treated with anticonvulsants), mechanical ventilation during the self-limited episodes of respiratory failure allows the patient to live a relatively normal life in the intervals. 3. Mechanical ventilation is indicated for chronic respiratory failure with normal mental state and a non progressive primary cause (e.g. after poliomyelitis or high cervical cord lesion) although the best quality of life one can offer the patient may not always be satisfactory to him. It is not indicated for chronic respiratory failure due to an irreversible cause which also causes coma (e.g. cerebral tumour, stroke, or brain stem death).
Neuromuscular and chest wall disorders
In the Pickwickian syndrome and in obstructive sleep apnoea, in which cor pulmonale is seen secondary to nocturnal hypoventilation, nocturnal mask CP AP has been shown to reduce nocturnal haemoglobin desaturation and correct right heart failure and daytime somnolence. 38 -4o (See the review on CP AP /PEEP in this issue.)
During general anaesthesia 41 The use of muscle relaxants requires mechanical ventilation to maintain alveolar ventilation 1. when muscle relaxation per se is needed (for example in body cavity surgery, in orthopaedics and also in tetanus and headinjured patients in the intensive care unit); 2. to permit light, balanced anaesthesia. In this 45 This applies particularly to acute type A lactic acidosis, whose prognosis is not improved by infusion of bicarbonate. 46 2. To cause cerebral vasoconstriction.
(a) Cerebral vasodilatation tends to increase cerebral blood volume and hence ICP, and reduction of PaC02 is a potent vasoconstrictor stimulus. 47 As cerebral hypoxia has not been shown at PaC02 above 25 mmHg (3.3 kPa),48,49 moderate hyperventilation to PaC02 28-35 mmHg (3.7 -4. 7 kPa) to reduce cerebral blood volume, has been recommended for the management of raised I CP. It is only effective for a few hours, however, as cerebral vascular tone is controlled by brain ICF [H +], which in turn is restored to normal over several hours by HC03 pumping out of the brain. 50 Furthermore, return of PaC02 to normal after 24 hours' reduction to 25 mmHg (3.3 kPa) will result in supranormal CBF severity of periventricular haemorrhage correlated with PaC02: the cost in terms of barotrauma of producing low PaC02 may not be worthwhile if the only gain is prevention of grades rand 11 periventricular haemorrhage which have a good prognosis. These results were disputed by Cooke in another retrospective study which found no reduction of incidence of periventricular haemorrhage with hypocapnia, and ten out of twelve babies with lowest PaC02 <25 mmHg (3.3 kPa) developed the condition. 61
and an increase in rcp, due to brain acidosis from normocarbia with a reduced brain [HCOj1. 51 ,52 (b) PaC02 reduction causes cerebral vasoconstriction in normal areas of brain which diverts blood to areas of focal brain pathology where the vessels are less responsive to PaC02. This is known as 'inverse steal' and depends on an upper limit to total cerebral blood flow. 53,54
3. To restore cerebrovascular autoregulation.
(a) PaC02 reduction may be used to restore cerebrovascular autoregulation around intracerebral lesions. After global brain hypoxia and in the non-diseased hemisphere of patients with stroke or brain tumour, autoregulation is lost due to lactic acid accumulation but can be restored by reducing PaC02 which restores ICF [H +], the final common path of cerebrovascular control. [55] [56] [57] Hypocarbia is effective where autoregulation is lost and C02 responsiveness retained but not where both are lost (i.e. in damaged areas of brain).55 (b) The use of hyperventilation has been suggested to prevent periventricular haemorrhage in premature neonates. There is evidence that impaired cerebral autoregulation is crucial in the causation of periventricular haemorrhage which is a major cause of mortality and neurological handicap among premature newborns. 58 ,59 One anecdotal retrospective study60 found that in 63 infants of birth weight below 1350 g, of those with a lowest PaC02 <25 mmHg (3.3 66 In hyperkinetic pulmonary hypertension, hyperventilation with 100070 oxygen can frequently reduce the labile but not the fixed component of raised pulmonary vascular resistance. It is the first line of treatment of pulmonary hypertensive crises after open heart surgery in children with nonrestrictive ventricular septal defects, truncus arteriosus, total anomalous pulmonary venous drainage and common atrioventricular canal. [70] [71] [72] Neither mechanical ventilation nor oxygen therapy affects PVR in postcapillary pulmonary hypertension. 66 In chronic parenchymal lung disease, pulmonary vascular resistance is tightly linked to Pa02, and large prospective trials have shown reduction in mortality (but not in pulmonary vascular resistance) in patients with chronic obstructive pulmonary disease using chronic ambulatory or nocturnal oxygen therapy. Similar data are not available for mechanical ventilation. However, as discussed above, nocturnal mechanical ventilation corrects right heart failure secondary to high pulmonary vascular resistance in neuromuscular and chest wall disorders, and nocturnal CPAP by nose mask has been reported to improve right heart failure due to reactive pulmonary hypertension in the Pickwickian syndrome. 4o (c) Persistent pulmonary hypertension of the newborn occurs in several disorders including perinatal asphyxia, meconium aspiration, pulmonary hypoplasia (including diaphragmatic hernia) and severe hyaline membrane disease. 73 Persistent pulmonary hypertension causes increasing hypoxaemia due to right-to-left shunting via the foramen ovale or ductus arteriosus, which in turn further raises pulmonary vascular resistance. The maladaptive type of persistent pulmonary hypertension (with structurally normal vessels) will respond better to hyperventilation with 100070 oxygen than those with precocious muscularisation of preacinar vessels, and much better than those with a hypoplastic pulmonary vascular bed. 74 Nonetheless, mechanical hyperventilation with 100070 oxygen to a critical PaC02 will reduce pulmonary vascular resistance and right-to-left shunting and improve oxygenation; it is the cornerstone of management of these infants, and vasodilator drug therapy plays a minor role. The cost of hyperventilation is increased risk of barotrauma, pulmonary oxygen toxicity and chronic lung disease 75 • 76 which develops after two to three days' hyperventilation and becomes itself an important cause of hypoxaemia. 77 Indications when CO 2 production is increased 1. In malignant hyperpyrexia, the early fall in pH is due to the rapid increase in PaC02 caused by a marked increase in C02 production by skeletal muscle. Increased alveolar ventilation (Y ~ is the only method of maintaining normal PaC02 in the face of increased Y co . 78, 79 Later in the condition when metab 2 0lic acidosis increases, mechanical hyperventilation can maintain relatively normal ECF and ICF pH despite large base deficits (see above).
In neurolept malignant syndrome where
there is increased heat and C02 production by skeletal muscle, mechanical hyperventilation may have a role, though the main place of IPPV is in management of respiratory failure (due to reduced chest wall compliance and aspiration pneumonia), the most frequent cause of death in neurolept malignant syndrome. 8o 3. There may also be a place for IPPV in other conditions with abnormally increased metabolism and CO 2 production, such as thyroid storm.
REDUCING THE WORK OF BREATHING IN CARDIORESPIRATORY FAILURE
In cardiorespiratory failure, respiratory muscle work calculated from flow-volume loops increases, and the ratio of oxygen consumption by respiratory muscles to whole body oxygen consumption (Vo R/VO T) increases from less than 5070 in n6rmals 2to about 20%.81,82 Respiratory muscle fatigue perpetuates cardiorespiratory failure and is due to imbalance between nutrient supply and demand: production of lactic acid interferes with aerobic glycolysis and impairs contraction by reducing Ca + + binding to troponin. 83 Respiratory muscle fatigue can be treated by reducing energy demand (treating pulmonary oedema, removing pulmonary secretions or reducing Vo R by mechanical ventilation and muscle relaiation) or by increasing supply (relieving hypoxaemia and acidosis, and improving cardiac output). Recovery in chronic respiratory muscle fatigue takes at least 24 hours even with complete respiratory muscle rest. 84,85 Conversely, the increased metabolic work needed to ventilate noncompliant lungs can precipitate cardiac failure. 86 Thus, increased pulmonary congestion augments work of breathing and vice versa. At present, mechanical ventilation is only recommended in heart failure when secondary respiratory failure occurs 87 but it would be logical to use IPPV earlier before severe cardiac decompensation occurs. In practice, however, there is not complete agreement on this point.
In acute cor pulmonale, enhanced right ventricular function follows improvement in gas exchange by mechanical ventilation as previously described.
In left ventricular failure, clinical and experimental experience suggest that V 0 R is increased, and may be reduced by mecha~ical ventilation with resulting improvement in the haemodynamic state. 8l ,88 However, some of these studies have been criticised on the grounds of faulty methodology89 and it has been pointed out that the errors in measurement of V02R/V02T are large. 9o However, positive pressure ventilation may also improve con tractility in the failing heart (see below) and allow use of sedation which reduces hypertension, tachycardia and heart work.
In experimental cardiogenic shock, where both increased energy demand (hyperventilation due to hypoxaemia, acidosis and hypotension) and reduced oxygen delivery contribute to respiratory muscle fatigue, death was caused by respiratory failure due to inability of the respiratory muscles to transform motor neuron activity into pressure, and was prevented by mechanical ventilation. 83 In clinical cardiogenic shock, mechanical ventilation has been recommended to be potentially life-saving. 81 After open heart surgery, several studies have shown that oxygen cost of breathing increases especially in older patients and those with chronic lung diseases,91-93 while others have failed to demonstrate this.94 This disparity in results may be due to the fact that V 0 R is higher when breathing spontaneously vi~ an endotracheal tube with or without IMV, than when extubated. The difference is presumably due to airway resistance and discomfort of endotracheal tube. 93 Based on the findings of Thung et al.,92 the accepted practice in the 1960s and early '70s was to ventilate patients routinely for six hours or more postoperatively. Associated benefits claimed were removal of lung secretions, avoidance of infection and major atelectasis, reduction of wound pain and prevention of haemothorax. 95 However, controlled trials in the early '80s showed no advantage conferred by mechanical ventilation for more than two hours after major cardiovascular surgery in adults, in terms of mortality or morbidity, haemodynamic or respiratory performance or ICU stay. In fact, patients extubated early postoperatively had a lower incidence of arrhythmia, lung collapse, stroke, tamponade and myocardial infarction than those ventilated more than six hours. 96, 97 Lichtenthal et al. found that 94% of patients could be extubated within 24 hours postoperatively and 45% within 90 minutes. 98 Even in paediatric cardiac surgery where practices have been more conservative, the trend is toward early extubation: 50-70% of all children can be extubated less than six hours postoperatively. Prolonged ventilation is more likely to be necessary with age less than three months, more complex lesions, and prolonged bypass, the main indications being respiratory failure and haemodynamic instability. 99 Before 1975, several authors had found that in patients with severe cardiac failure, cardiac performance improved when positive pressure ventilation was started, and deteriorated when it was withdrawn. [109] [110] [111] [112] In 1975, Goldberg et al. reported pulmonary vascular congestion during continuous negative pressure breathing (CNPB) in man and attributed this to increased left ventricular afterload due to the more negative intrathoracic pressure in CNPB. 113 The explanation for this is that if afterload on heart muscle is increased, both velocity and extent of shortening are reduced. 114 Afterload is ventricular wall tension (T) and by Laplace's law:
where Pi and Po are the pressures inside and outside a sphere, r is the radius of the sphere and H is the wall thickness. 115 Buda et aI, 116 found that the regression line Anaesthesia and Intensive Care, Vol. 14. No. 3, August, 1986 relating end-systolic volume to transmural pressure more closely fitted known myocardial function curves than does that of end-systolic volume vs cavity pressure, Thus, increased intrathoracic pressure in continuous positive pressure ventilation (CPPV) reduces ventricular transmural pressure which reduces afterload and increases contractility,
In the early 1960s, the conventional explanation of the finding that spontaneous inspiration reduces left ventricular stroke volume was that inspiration increases pulmonary vascular capacity which reduces venous return to the left ventricle and thus left ventricular stroke volume. Conversely, a mechanical positive pressure breath squeezes blood out of the lungs, increasing left ventricular stroke volume and BP, 117 However, if this view were correct, on spontaneous inspiration venous return to the left ventricle would fall and left ventricular end-diastolic volume would decrease. In fact, several studies showed that L VEDV increases during the Muller manoeuvre and during spontaneous deep inhalation and that left ventricular performance declined. The reverse occurred during the Valsalva manoeuvre,"6,18-120 This refutes the conventional explanation and confirms that of Goldberg et al,: i.e. reduced left ventricular afterload due to increased intrathoracic pressure improves left ventricular performance, Thus, the findings, mentioned above, of improved cardiac performance during IPPV in patients with severe cardiac failure are explained,109-ll2 as are the later findings of Mathru et al., Grace and Greenbaum, Rasanen et aI" who found that raised intrathoracic pressure improved left ventricular performance in patients with severe left ventricular dysfunction, but reduced cardiac output in those with normal contractility.l2l·123 However, Nikki et al. in nine patients with pulmonary oedema after myocardial infarction found that cardiac performance improved when continuous mandatory ventilation (CMV) was changed to IMV (i.e, mean intrathoracic pressure fell),124 Their patients had quite high cardiac indices and left ventricular stroke work indices and may not have fallen into the poor performance group of the other authors.
In summary, posItIve pressure ventilation may be regarded as a non-pharmacological method of support for the failing left ventricle l25 and during weaning from CPPV in such patients, deterioration in left ventricular function should be anticipated and preventive measures such as vasodilator and inotropic drugs used.
PROPHYLACTIC POSIVITE PRESSURE VENTILATION 1. The prevention of ARDS using PEEP/CPAP is discussed elsewhere in this symposium. Early studies in dogs showed that ventilation of the unperfused lungs on CPB reduced the severity of these histological changes and improved compliance though there was no improvement in pulmonary vascular resistance. CP AP 5 cm H20 (0.5 kPa) was no better than using no endexpiratory pressures in this respect. 128.129 Later studies in man showed no improvement in compliance, intrapulmonary shunt or gas exchange when IPPV was used during bypass 131 although Sullivan et al. using CPAP 10 cm H20 (1.0 kPa) found no deterioration in lung mechanics or gas exchange after 150 minutes CPB.130
Prevention

INTERMITTENT POSITIVE PRESSURE
BREATHING Since 1946, the use of IPPB by triggered, pressure-cycled ventilators via mask or mouthpiece has been advocated in acute asthma, COPD, pneumonia and in the prevention of lung complications after thoracic and abdominal surgery and after major trauma. 131 In acute asthma, benefits claimed are: more effective delivery of bronchodilator aerosols, improved gas exchange and rest of fatigued respiratory muscles (see above). However, the absorbed dose of bronchodilator is more variable with IPPB than with nebuliser delivery22 and while it was claimed that IPPB delivers the drug to underventilated areas of lung, in fact most of the increase in V A is delivered to alveolar dead space and only a small fraction enters low V IQ units. 132
There is no evidence that IPPB reduces work of breathing in acute asthma and it may increase it severely especially in children and confused patients who find co-ordination with the ventilator impossible. 22.133 In normal and asthmatic children, IPPB increases airway resistance by acting as a nonspecific stimulus like cold or noxious gas. 134 Bronchodilator drugs should, therefore, be given by nebuliser rather than IPPB and respiratory failure treated on its merits using mechanical ventilation.
IPPB has been used in chronic obstructive pulmonary disease on a chronic domiciliary basis and in treatment of acute exacerbations. Advantages claimed include: improved gas exchange with resulting improvement in cor pulmonale, reduced respiratory muscle fatigue and increased mucus clearance due to increased airway diameter. However, Curtis et al. 135 found no benefit of domiciliary IPPB in 78 patients over four years, in spirometry blood gases or mortality. In fact, deterioration in FEV 1.0 was twice as rapid with IPPB as in controls. Similarly, the large IPPB Trial Group Study in 1983 found no advantage of IPPB compared with nebulised bronchodilator in mortality, time in hospital, quality of life, blood gases or spirometry. 136
In acute exacerbation of COPD, many patients have reported subjective improvement in dyspnoea and ability to clear secretions I31 ,135,137 and some centres have advocated IPPB when acute respiratory failure is associated with sputum retention. 138 ,1J9 The present consensus, however, is that IPPB cannot be justified in COPD,133 because of its known disadvantages which include pneumothorax, depressed cardiac output, paradoxical increase in dyspnoea and work of breathing, C02 narcosis due to use of high FI02, respiratory alkalosis with subsequent arrhythmia and failure of respiratory drive, accelerated deterioration of lung function Il5 and risk of nosocomial infection. IJO,14O
In a controlled, non-randomised study, Anderson et al. found an eightfold reduction in the incidence of significant lung complications with the early postoperative use of IPPB. Preand postoperative IPPB subsequently became widely used for prevention of lung complications particularly in non-ambulant patients, those with chronic lung disease and those who could not cough. 141,142 Reduced lung compliance, reduced work per breath and resulting sputum retention found after thoracic and abdominal surgery are major causes of postoperative lung disease l43 and were potentially remediable by IPPB. However, since the early 1960s, several studies failed to show any benefit of IPPB compared with no treatment. 144, 145 A recent prospective randomised trial of 172 patients showed that IPPB or incentive spirometry or deep breathing exercises halved the incidence of significant lung complications after abdominal surgery but only incentive spirometry was free of complications and able to shorten hospital stay. 146 Similarly, a prospective randomised trial of 54 patients with established pneumonia found no improvement in rate and extent of chest X-ray clearing, duration of hospital stay and mortality with IPPB and physiotherapy compared with controls. 147 Care, Vol. 14, No. 3, August, 1986 SIMULTANEOUS VENTILATION-COMPRESSION CARDIOPULMONARY RESUSCITATION (SVC-CPR) Since closed cardiac massage was introduced in 1960, it was understood that blood moves from heart to great vessels during CPR due to compression of the heart between sternum and vertebrae. 148 However, in 1978 the J ohns Hopkins group showed that blood pressure and carotid blood flow were higher when positive pressure inflation and sternal compression were simultaneous, both in dogs and man. 149 ,150 Moreover, it was found that the AV valves were incompetent during CPR 151 and that pressures in all heart chambers and in the aorta were equal to each other and equal to intrathoracic pressure. A functional and anatomical valve was found at the thoracic outlet which allowed forward flow and establishment of an aortovenous pressure difference during compression. 152 Thus, in SVC-CPR the heart and thorax act like a bag-in-bottle to produce aortic blood flow.
Anaesthesia and Intensive
These studies explained the finding of Criley et al. that repeated coughing can maintain adequate cerebral perfusion pressure to preserve consciousness during ventricular fibrillation. 153 However, carotid blood flow is not the same as cerebral blood flow since the carotids supply extracranial tissues such as scalp and tongue which may form a lowresistance pathway, preferentially perfused during CPR. 154, 155 When ICP is already raised, it rises further simultaneously with chest compression and the resulting rise in blood pressure. This is due to reflux of venous blood from the thorax and will be accentuated during SVC-CPR with reflux of blood into the head via the vertebral venous plexus. The increase in ICP is such that cerebral perfusion pressure may be as low as 10 mmHg (1.3 kPa). 156 The confirmation of these latter suspicions came from papers by Arai et al. in 1984 157 who found no difference in sagittal sinus blood flow between conventional CPR and SVC-CPR though open chest CPR (OCCPR) was better than either. Bircher and Safar l58 found no difference in survival or neurological outcome after four minutes' VF in dogs between CCPR and SVC-CPR, though again OCCPR was significantly better than either. Thus, at present SVC-CPR appears to have no advantage over conventional CPR, which is still the method recommended by the American Heart Association and the Australian Resuscitation Council.
INTERNAL SPLINTING OF FLAIL CHEST The use of IPPV as a method of internal pneumatic splinting for the management of flail chest was first introduced by A very et al. in 1956. 159 The method fell into disuse in the mid-'sixties, giving way to treatment of respiratory failure on its merits with treatment of underlying lung contusion by fluid restriction, diuretics, steroids, albumen, adequate analgesia and tracheal toilet. 160, 161 However, despite the change in approach, there has not been a significant improvement in mortality from flail chest over the last twenty years despite concomitant improvements in intensive care techniques. 162 Most of the mortality is among patients with extrathoracic injuries associated with their flail chest.
